Your browser doesn't support javascript.
loading
NOX4 is a major regulator of cord blood-derived endothelial colony-forming cells which promotes post-ischaemic revascularization.
O'Neill, Karla M; Campbell, David C; Edgar, Kevin S; Gill, Eleanor K; Moez, Arya; McLoughlin, Kiran J; O'Neill, Christina L; Dellett, Margaret; Hargey, Ciarán J; Abudalo, Rawan A; O'Hare, Michael; Doyle, Philip; Toh, Tinrui; Khoo, Joshua; Wong, June; McCrudden, Cian M; Meloni, Marco; Brunssen, Coy; Morawietz, Henning; Yoder, Mervin C; McDonald, Denise M; Watson, Chris J; Stitt, Alan W; Margariti, Andriana; Medina, Reinhold J; Grieve, David J.
Afiliação
  • O'Neill KM; Centre for Experimental Medicine, Wellcome-Wolfson Institute, Queen's University Belfast, 97 Lisburn Road, Belfast BT9 7AE, UK.
  • Campbell DC; Centre for Experimental Medicine, Wellcome-Wolfson Institute, Queen's University Belfast, 97 Lisburn Road, Belfast BT9 7AE, UK.
  • Edgar KS; Centre for Experimental Medicine, Wellcome-Wolfson Institute, Queen's University Belfast, 97 Lisburn Road, Belfast BT9 7AE, UK.
  • Gill EK; Centre for Experimental Medicine, Wellcome-Wolfson Institute, Queen's University Belfast, 97 Lisburn Road, Belfast BT9 7AE, UK.
  • Moez A; Centre for Experimental Medicine, Wellcome-Wolfson Institute, Queen's University Belfast, 97 Lisburn Road, Belfast BT9 7AE, UK.
  • McLoughlin KJ; Centre for Experimental Medicine, Wellcome-Wolfson Institute, Queen's University Belfast, 97 Lisburn Road, Belfast BT9 7AE, UK.
  • O'Neill CL; Centre for Experimental Medicine, Wellcome-Wolfson Institute, Queen's University Belfast, 97 Lisburn Road, Belfast BT9 7AE, UK.
  • Dellett M; Centre for Experimental Medicine, Wellcome-Wolfson Institute, Queen's University Belfast, 97 Lisburn Road, Belfast BT9 7AE, UK.
  • Hargey CJ; Centre for Experimental Medicine, Wellcome-Wolfson Institute, Queen's University Belfast, 97 Lisburn Road, Belfast BT9 7AE, UK.
  • Abudalo RA; Centre for Experimental Medicine, Wellcome-Wolfson Institute, Queen's University Belfast, 97 Lisburn Road, Belfast BT9 7AE, UK.
  • O'Hare M; Centre for Experimental Medicine, Wellcome-Wolfson Institute, Queen's University Belfast, 97 Lisburn Road, Belfast BT9 7AE, UK.
  • Doyle P; Centre for Experimental Medicine, Wellcome-Wolfson Institute, Queen's University Belfast, 97 Lisburn Road, Belfast BT9 7AE, UK.
  • Toh T; Centre for Experimental Medicine, Wellcome-Wolfson Institute, Queen's University Belfast, 97 Lisburn Road, Belfast BT9 7AE, UK.
  • Khoo J; Centre for Experimental Medicine, Wellcome-Wolfson Institute, Queen's University Belfast, 97 Lisburn Road, Belfast BT9 7AE, UK.
  • Wong J; Centre for Experimental Medicine, Wellcome-Wolfson Institute, Queen's University Belfast, 97 Lisburn Road, Belfast BT9 7AE, UK.
  • McCrudden CM; School of Pharmacy, Queen's University Belfast, Belfast BT9 7BL, UK.
  • Meloni M; Sanofi R&D, 91380 Chilly-Mazarin, France.
  • Brunssen C; Division of Vascular Endothelium and Microcirculation, Department of Medicine III, Medical Faculty and University Clinics Carl Gustav Carus, Technische Universität Dresden, D-01307 Dresden, Germany.
  • Morawietz H; Division of Vascular Endothelium and Microcirculation, Department of Medicine III, Medical Faculty and University Clinics Carl Gustav Carus, Technische Universität Dresden, D-01307 Dresden, Germany.
  • Yoder MC; Department of Pediatrics, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
  • McDonald DM; Centre for Experimental Medicine, Wellcome-Wolfson Institute, Queen's University Belfast, 97 Lisburn Road, Belfast BT9 7AE, UK.
  • Watson CJ; Centre for Experimental Medicine, Wellcome-Wolfson Institute, Queen's University Belfast, 97 Lisburn Road, Belfast BT9 7AE, UK.
  • Stitt AW; Centre for Experimental Medicine, Wellcome-Wolfson Institute, Queen's University Belfast, 97 Lisburn Road, Belfast BT9 7AE, UK.
  • Margariti A; Centre for Experimental Medicine, Wellcome-Wolfson Institute, Queen's University Belfast, 97 Lisburn Road, Belfast BT9 7AE, UK.
  • Medina RJ; Centre for Experimental Medicine, Wellcome-Wolfson Institute, Queen's University Belfast, 97 Lisburn Road, Belfast BT9 7AE, UK.
  • Grieve DJ; Centre for Experimental Medicine, Wellcome-Wolfson Institute, Queen's University Belfast, 97 Lisburn Road, Belfast BT9 7AE, UK.
Cardiovasc Res ; 116(2): 393-405, 2020 02 01.
Article em En | MEDLINE | ID: mdl-30937452
AIMS: Cord blood-derived endothelial colony-forming cells (CB-ECFCs) are a defined progenitor population with established roles in vascular homeostasis and angiogenesis, which possess low immunogenicity and high potential for allogeneic therapy and are highly sensitive to regulation by reactive oxygen species (ROS). The aim of this study was to define the precise role of the major ROS-producing enzyme, NOX4 NADPH oxidase, in CB-ECFC vasoreparative function. METHODS AND RESULTS: In vitro CB-ECFC migration (scratch-wound assay) and tubulogenesis (tube length, branch number) was enhanced by phorbol 12-myristate 13-acetate (PMA)-induced superoxide in a NOX-dependent manner. CB-ECFCs highly-expressed NOX4, which was further induced by PMA, whilst NOX4 siRNA and plasmid overexpression reduced and potentiated in vitro function, respectively. Increased ROS generation in NOX4-overexpressing CB-ECFCs (DCF fluorescence, flow cytometry) was specifically reduced by superoxide dismutase, highlighting induction of ROS-specific signalling. Laser Doppler imaging of mouse ischaemic hindlimbs at 7 days indicated that NOX4-knockdown CB-ECFCs inhibited blood flow recovery, which was enhanced by NOX4-overexpressing CB-ECFCs. Tissue analysis at 14 days revealed consistent alterations in vascular density (lectin expression) and eNOS protein despite clearance of injected CB-ECFCs, suggesting NOX4-mediated modulation of host tissue. Indeed, proteome array analysis indicated that NOX4-knockdown CB-ECFCs largely suppressed tissue angiogenesis, whilst NOX4-overexpressing CB-ECFCs up-regulated a number of pro-angiogenic factors specifically-linked with eNOS signalling, in parallel with equivalent modulation of NOX-dependent ROS generation, suggesting that CB-ECFC NOX4 signalling may promote host vascular repair. CONCLUSION: Taken together, these findings indicate a key role for NOX4 in CB-ECFCs, thereby highlighting its potential as a target for enhancing their reparative function through therapeutic priming to support creation of a pro-reparative microenvironment and effective post-ischaemic revascularization.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Músculo Esquelético / Neovascularização Fisiológica / Células Progenitoras Endoteliais / NADPH Oxidase 4 / Isquemia Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Cardiovasc Res Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Músculo Esquelético / Neovascularização Fisiológica / Células Progenitoras Endoteliais / NADPH Oxidase 4 / Isquemia Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Cardiovasc Res Ano de publicação: 2020 Tipo de documento: Article